NCT02438085 Prospective Registry of Acute Coronary Syndromes in Ferrara
| NCT ID | NCT02438085 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital of Ferrara |
| Condition | Acute Coronary Syndromes |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2014-06 |
| Primary Completion | 2028-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2014-06 with a primary completion date of 2028-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The ARYOSTO has been designed to describe the clinical epidemiology and the current management of acute coronary syndromes (ACS) in the area of Ferrara. Especially, the Authors will evaluate the medical and interventional management of ACS patients admitted to hospitals in the area of Ferrara and receiving coronary artery angiography and percutaneous coronary intervention (PCI) in the hub center of Ferrara (Azienda Ospedaliera Universitaria di Ferrara, Cona (FE), Italy)
Eligibility Criteria
Inclusion Criteria: * age \>18 years * hospital admission for acute coronary syndromes * resident in the Ferrara area Exclusion Criteria: * none
Contact & Investigator
Frequently Asked Questions
Who can join the NCT02438085 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Coronary Syndromes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02438085 currently recruiting?
Yes, NCT02438085 is actively recruiting participants. Contact the research team at veronica.lodolini@student.unife.it for enrollment information.
Where is the NCT02438085 trial being conducted?
This trial is being conducted at Cona, Italy.
Who is sponsoring the NCT02438085 clinical trial?
NCT02438085 is sponsored by University Hospital of Ferrara. The trial plans to enroll 10,000 participants.